97 related articles for article (PubMed ID: 36184073)
21. Promoter hypermethylation of KLF4 inactivates its tumor suppressor function in cervical carcinogenesis.
Yang WT; Zheng PS
PLoS One; 2014; 9(2):e88827. PubMed ID: 24551169
[TBL] [Abstract][Full Text] [Related]
22. DNA methylation regulated microRNAs in human cervical cancer.
Varghese VK; Shukla V; Kabekkodu SP; Pandey D; Satyamoorthy K
Mol Carcinog; 2018 Mar; 57(3):370-382. PubMed ID: 29077234
[TBL] [Abstract][Full Text] [Related]
23. Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer.
Zhang Z; Huettner PC; Nguyen L; Bidder M; Funk MC; Li J; Rader JS
Oncogene; 2006 Aug; 25(39):5436-45. PubMed ID: 16607278
[TBL] [Abstract][Full Text] [Related]
24. Promoter methylation in the PTCH gene in cervical epithelial cancer and ovarian cancer tissue as studied by eight novel Pyrosequencing® assays.
Löf-Öhlin ZM; Levanat S; Sabol M; Sorbe B; Nilsson TK
Int J Oncol; 2011 Mar; 38(3):685-92. PubMed ID: 21206974
[TBL] [Abstract][Full Text] [Related]
25. Association of epigenetic inactivation of the WRN gene with anticancer drug sensitivity in cervical cancer cells.
Masuda K; Banno K; Yanokura M; Tsuji K; Kobayashi Y; Kisu I; Ueki A; Yamagami W; Nomura H; Tominaga E; Susumu N; Aoki D
Oncol Rep; 2012 Oct; 28(4):1146-52. PubMed ID: 22797812
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma.
Omura N; Li CP; Li A; Hong SM; Walter K; Jimeno A; Hidalgo M; Goggins M
Cancer Biol Ther; 2008 Jul; 7(7):1146-56. PubMed ID: 18535405
[TBL] [Abstract][Full Text] [Related]
27. Mutational, epigenetic and expressional analyses of caveolin-1 gene in cervical cancers.
Chan TF; Su TH; Yeh KT; Chang JY; Lin TH; Chen JC; Yuang SS; Chang JG
Int J Oncol; 2003 Sep; 23(3):599-604. PubMed ID: 12888893
[TBL] [Abstract][Full Text] [Related]
28. SOX17 expression and its down-regulation by promoter methylation in cervical adenocarcinoma in situ and adenocarcinoma.
Hopman ANH; Moshi JM; Hoogduin KJ; Ummelen M; Henfling MER; van Engeland M; Wouters KAD; Stoop H; Looijenga LHJ; Ramaekers FCS
Histopathology; 2020 Feb; 76(3):383-393. PubMed ID: 31444787
[TBL] [Abstract][Full Text] [Related]
29. Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer.
Szmida E; Karpiński P; Leszczynski P; Sedziak T; Kielan W; Ostasiewicz P; Sasiadek MM
J Appl Genet; 2015 May; 56(2):185-92. PubMed ID: 25366420
[TBL] [Abstract][Full Text] [Related]
30. OPCML gene promoter methylation and gene expression in tumor and stroma cells of invasive cervical carcinoma.
Ye F; Zhang SF; Xie X; Lu WG
Cancer Invest; 2008 Jul; 26(6):569-74. PubMed ID: 18584347
[TBL] [Abstract][Full Text] [Related]
31. [p16 gene CpG methylation in cervical squamous cell carcinoma and HPV16 infection in Uyghur women].
Yuan M; Li A; Yao L; Shen G; Cheng J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jan; 38(1):48-53. PubMed ID: 23406849
[TBL] [Abstract][Full Text] [Related]
32. [Correlation between DNA Methylation of ZNF772 Promoter Region and Cervical Cancer].
Li M; Li O; Sun J; Zheng X; Ma D
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Apr; 42(2):164-171. PubMed ID: 32385021
[No Abstract] [Full Text] [Related]
33. Epigenetic alterations of CYLD promoter modulate its expression in gastric adenocarcinoma: A footprint of infections.
Ghadami E; Nikbakhsh N; Fattahi S; Kosari-Monfared M; Ranaee M; Taheri H; Amjadi-Moheb F; Godazandeh G; Shafaei S; Nosrati A; Pilehchian Langroudi M; Samadani AA; Amirbozorgi G; Mirnia V; Akhavan-Niaki H
J Cell Physiol; 2019 Apr; 234(4):4115-4124. PubMed ID: 30132887
[TBL] [Abstract][Full Text] [Related]
34. The synergic effect of HPV infection and epigenetic anomaly of the p16 gene in the development of cervical cancer.
Ahmad A; Raish M; Shahid M; Batra S; Batra V; Husain SA
Cancer Biomark; 2017 Jul; 19(4):375-381. PubMed ID: 28453456
[TBL] [Abstract][Full Text] [Related]
35. WT1 CpG islands methylation in human lung cancer: a pilot study.
Bruno P; Gentile G; Mancini R; De Vitis C; Esposito MC; Scozzi D; Mastrangelo M; Ricci A; Mohsen I; Ciliberto G; Simmaco M; Mariotta S
Biochem Biophys Res Commun; 2012 Sep; 426(3):306-9. PubMed ID: 22925896
[TBL] [Abstract][Full Text] [Related]
36. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
[TBL] [Abstract][Full Text] [Related]
37. Alterations in gene promoter methylation and transcript expression induced by cisplatin in comparison to 5-Azacytidine in HeLa and SiHa cervical cancer cell lines.
Sood S; Srinivasan R
Mol Cell Biochem; 2015 Jun; 404(1-2):181-91. PubMed ID: 25772483
[TBL] [Abstract][Full Text] [Related]
38. Individualized analysis reveals CpG sites with methylation aberrations in almost all lung adenocarcinoma tissues.
Yan H; Guan Q; He J; Lin Y; Zhang J; Li H; Liu H; Gu Y; Guo Z; He F
J Transl Med; 2017 Feb; 15(1):26. PubMed ID: 28178989
[TBL] [Abstract][Full Text] [Related]
39. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
[TBL] [Abstract][Full Text] [Related]
40. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.
Yu MY; Tong JH; Chan PK; Lee TL; Chan MW; Chan AW; Lo KW; To KF
Int J Cancer; 2003 Jun; 105(2):204-9. PubMed ID: 12673680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]